MNDT yields 8.75% · JNJ yields 2.13%● Live data
📍 MNDT pulled ahead of the other in Year 1
Combined, MNDT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MNDT + JNJ for your $10,000?
Mandiant, Inc. engages in the provision of cyber security solutions. The company, through the Mandiant Advantage SaaS platform, offers threat intelligence, security validation, attack surface management and security automation, as well as managed and consulting services. It also provides Advantage Platform, a multi-vendor XDR platform that delivers the company's expertise and frontline intelligence to security teams; Managed Defense, a solution with comprehensive protection from advanced and emerging threats; and Mandiant Academy, which provides cyber security training services. In addition, the company offers incident response, ransomware, risk management, targeted attack testing, cyber defense transformation, identity first security, industrial control systems and operational technology, cloud architecture, cyber security due diligence, and threat intelligence services. It provides its solutions and services under the Mandiant brand to telecommunications, technology, financial services, public utilities, healthcare, and oil and gas industries, the Unites States and international governmental agencies, as well as educational and nonprofit organizations. The company was formerly known as FireEye, Inc. and changed its name to Mandiant, Inc. in October 2021. Mandiant, Inc. was incorporated in 2004 and is headquartered in Reston, Virginia.
Full MNDT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.